Proposal to amend the Articles of Incorporation to shorten the term of directors from the current two years to one year, to be submitted at the shareholders meeting on June 11, 2026.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"2664","jir_company_name":"Kawachi Pharmaceutical Co., Ltd.","jir_importance":"\u2605\u2605\u2606\u2606\u2606","jir_publication_date":"2026-04-28","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/04\/2664-20260428-04.pdf","jir_short_summary":"Proposal to amend the Articles of Incorporation to shorten the term of directors from the current two years to one year, to be submitted at the shareholders meeting on June 11, 2026.","jir_summary":"### Outline of the Amendment to the Articles of Incorporation\nKawachi Pharmaceutical Co., Ltd. has resolved a partial amendment to the Articles of Incorporation to shorten the term of directors from the current two years to one year, aiming to clarify management responsibility, establish a management structure capable of swift response to changes in the business environment, and strengthen corporate governance. This amendment will be submitted at the 59th Annual Shareholders Meeting scheduled for June 11, 2026, and is expected to take effect on the same day.\n\n### Regarding the Shareholders Meeting and Transitional Measures\nThe shareholders meeting to approve the amendment to the Articles of Incorporation is scheduled for June 11, 2026. As a transitional measure, the term of directors appointed at the 58th Annual Shareholders Meeting held on June 11, 2025 is set to continue until the conclusion of the 60th Annual Shareholders Meeting scheduled for June 2027. This measure coordinates the expiration timing of the current directors' terms.","jir_financial_highlights":"Term of Directors: Until the conclusion of the regular shareholders meeting relating to the last business year ending within one year (Shortened from current two years)\nEffective Date of Articles of Incorporation Amendment: 2026-06-11 (New)\nScheduled Date for the 59th Annual Shareholders Meeting: 2026-06-11 (New)","jir_category":"","jir_hashtags":"#KawachiPharmaceutical, #ArticlesOfIncorporationAmendment, #CorporateGovernance, #JapaneseStocks","jir_key_figures":"Term of Directors: shortened to one year (currently two years)\nEffective Date of Articles of Incorporation Amendment: 2026-06-11\nScheduled Date for the 59th Annual Shareholders Meeting: 2026-06-11","jir_meta_title":"[Kawachi Pharmaceutical] Announcement of Articles of Incorporation Amendment to Shorten Director Term to One Year | June 2026","jir_meta_description":"Kawachi Pharmaceutical Co., Ltd. plans to submit a partial amendment of its Articles of Incorporation to shorten the term of directors from two years to one year at the shareholders meeting on June 11, 2026. The amendment aims to clarify management responsibility and strengthen governance.","jir_og_title":"[Kawachi Pharmaceutical] Announcement of Articles of Incorporation Amendment to Shorten Director Term to One Year | June 2026","jir_og_description":"Kawachi Pharmaceutical plans to implement an Articles of Incorporation amendment to shorten the term of directors to one year on June 11, 2026, aiming to strengthen the management structure.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":16960,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"general_ir","footnotes":""},"sector":[],"importance":[],"class_list":["post-43682","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n